Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Dalla Man, C; Bock, G; Giesler, PD; Serra, DB; Ligueros Saylan, M; Foley, JE; Camilleri, M; Toffolo, G; Cobelli, C; Rizza, RA; Vella, A.
Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes.
Diabetes Care. 2009; 32(1):14-18
Doi: 10.2337/dc08-1512
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Treiber Gerlies
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Adamantane - analogs & derivatives
-
Blood Glucose - drug effects
-
C-Peptide - blood
-
Cross-Over Studies -
-
Diabetes Mellitus, Type 2 - drug therapy
-
Digestion - drug effects
-
Dipeptidyl-Peptidase IV Inhibitors - therapeutic use
-
Double-Blind Method -
-
Glucagon - blood
-
Humans -
-
Hypoglycemic Agents - therapeutic use
-
Insulin - blood
-
Nitriles - therapeutic use
-
Placebos -
-
Postprandial Period - drug effects
-
Pyrrolidines - therapeutic use
-
Satiety Response - drug effects